Lisanti Capital Growth LLC boosted its holdings in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 63.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 372,407 shares of the medical technology company’s stock after acquiring an additional 145,120 shares during the period. Alphatec accounts for about 1.9% of Lisanti Capital Growth LLC’s investment portfolio, making the stock its 7th largest holding. Lisanti Capital Growth LLC’s holdings in Alphatec were worth $7,835,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of the business. Creative Planning lifted its position in Alphatec by 0.9% during the 3rd quarter. Creative Planning now owns 58,654 shares of the medical technology company’s stock valued at $853,000 after acquiring an additional 534 shares during the period. Valeo Financial Advisors LLC lifted its position in Alphatec by 2.1% during the 3rd quarter. Valeo Financial Advisors LLC now owns 41,296 shares of the medical technology company’s stock valued at $600,000 after acquiring an additional 846 shares during the period. Arizona State Retirement System lifted its position in Alphatec by 2.8% during the 3rd quarter. Arizona State Retirement System now owns 34,603 shares of the medical technology company’s stock valued at $503,000 after acquiring an additional 949 shares during the period. Oppenheimer Asset Management Inc. lifted its position in Alphatec by 9.9% during the 4th quarter. Oppenheimer Asset Management Inc. now owns 15,075 shares of the medical technology company’s stock valued at $317,000 after acquiring an additional 1,353 shares during the period. Finally, ProShare Advisors LLC lifted its position in Alphatec by 8.2% during the 4th quarter. ProShare Advisors LLC now owns 21,470 shares of the medical technology company’s stock valued at $452,000 after acquiring an additional 1,633 shares during the period. 66.35% of the stock is owned by hedge funds and other institutional investors.
Alphatec Stock Up 0.5%
NASDAQ:ATEC opened at $8.27 on Friday. The firm has a market cap of $1.27 billion, a P/E ratio of -10.09 and a beta of 0.96. The company has a debt-to-equity ratio of 40.35, a quick ratio of 1.12 and a current ratio of 1.90. Alphatec Holdings, Inc. has a fifty-two week low of $6.82 and a fifty-two week high of $23.29. The firm has a 50-day simple moving average of $10.32 and a two-hundred day simple moving average of $15.20.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on the stock. Canaccord Genuity Group lowered their price target on shares of Alphatec from $25.00 to $23.00 and set a “buy” rating for the company in a research report on Wednesday, May 6th. Needham & Company LLC reduced their price objective on shares of Alphatec from $25.00 to $14.00 and set a “buy” rating for the company in a research note on Wednesday, May 6th. TD Cowen reduced their price objective on shares of Alphatec from $20.00 to $11.00 and set a “buy” rating for the company in a research note on Wednesday, May 6th. Lake Street Capital restated a “buy” rating and set a $15.00 price objective on shares of Alphatec in a research note on Wednesday, May 6th. Finally, Piper Sandler restated an “overweight” rating and set a $14.00 price objective (down from $25.00) on shares of Alphatec in a research note on Wednesday, May 6th. Ten analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $18.58.
Read Our Latest Report on Alphatec
Insider Activity at Alphatec
In other news, EVP Craig E. Hunsaker sold 82,765 shares of Alphatec stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $12.45, for a total value of $1,030,424.25. Following the completion of the sale, the executive vice president directly owned 1,726,209 shares in the company, valued at $21,491,302.05. The trade was a 4.58% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Scott Lish sold 260,535 shares of Alphatec stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average price of $12.30, for a total transaction of $3,204,580.50. Following the completion of the sale, the chief operating officer owned 815,704 shares of the company’s stock, valued at $10,033,159.20. This represents a 24.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 629,189 shares of company stock valued at $7,801,589. Insiders own 13.48% of the company’s stock.
About Alphatec
Alphatec Holdings, Inc (NASDAQ: ATEC) is a medical technology company focused on the design, development and commercialization of products for the surgical correction of degenerative spinal conditions. The company’s portfolio centers on interbody implants, biologics, fixation devices and surgical planning tools intended to improve patient outcomes in spinal fusion procedures. Alphatec’s flagship offerings include customizable interbody cages, bone graft materials and specialized instrumentation designed for minimally invasive and open spinal surgeries.
Founded as Alphatec Spine in 1985 and rebranded as Alphatec Holdings in 2018, the company has grown from a single-product organization into a multi-platform innovator in the spine market.
Featured Articles
- Five stocks we like better than Alphatec
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Want to see what other hedge funds are holding ATEC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report).
Receive News & Ratings for Alphatec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec and related companies with MarketBeat.com's FREE daily email newsletter.
